In‐vitro evaluation of a ciprofloxacin‐ and ivacaftor‐coated sinus stent against <i>Pseudomonas aeruginosa</i> biofilms

Abstract

The CISS maintains a uniform coating and sustained delivery of drugs providing a marked reduction in P aeruginosa biofilm formation. Further studies evaluating the efficacy of CISS in a preclinical model are planned.